RLM Realm Thera.

TIDMPURI

RNS Number : 2036Z

PuriCore Plc

05 March 2013

PuriCore plc

("PuriCore" or the "Company")

5 March 2013

Board and Organisational Changes

PuriCore (LSE: PURI), the water-based, clean technology company, today announces Board and organisational changes. Marella Thorell has been appointed Finance Director and will serve as an Executive Director with immediate effect and Peter Larkin, a leading key opinion leader in the US supermarket retail industry, has been appointed Non-Executive Director with effect from 1 April 2013.

Ms. Thorell, has been a key member of the PuriCore senior leadership team, most recently as Vice President of Human Resources and Administration and Company Secretary. She offers more than 24 years of experience in finance, operations, and human resources. Prior to joining PuriCore, she was the President of Thorell Consulting, a business consulting firm. Ms. Thorell was previously with Campbell Soup Company (NYSE: CPB), where she held a number of financial and management roles. She began her career and earned her CPA accounting qualification with Ernst & Young, LLP in Philadelphia. Ms. Thorell holds a BS in Business from Lehigh University.

Peter Larkin has more than 30 years of experience in the US supermarket retail industry. He is currently the President and CEO of the National Grocers Association, the national trade association representing independent retail and wholesale grocers of the food distribution industry. Prior to establishing his own government relations consulting firm in 2008, Mr. Larkin was the President and CEO of the California Grocers Association and Vice President of State Government Relations and Environmental Affairs for the Food Marketing Institute in Washington, DC. Previously, he managed government and media relations programs for The Kroger Co., the Tobacco Institute, and Philip Morris U.S.A. After earning a bachelor's degree in political science from the University of Vermont in 1976, he served as legislative assistant to U.S. Representative Donald Mitchell (R-NY).

The Company confirms that there is no additional information about Mr. Larkin or Ms. Thorell that the Company is required to disclose under paragraph 9.6.13(1) to (6) of the Listing Rules of the UK Listing Authority.

Michael Ashton, Executive Chairman, said:

"Marella has been instrumental to the growth and success of our US operations, and we are confident of her ability to provide strong financial leadership. Peter offers PuriCore extensive industry experience and will provide significant insight to our supermarket retail business, which accounts for nearly 50 per cent. of our total revenues. We welcome the contribution and guidance of both Marella and Peter, whose combined experience will be invaluable to the Company as we continue to grow the business in existing and new markets."

Enquiries:

 
 UK                          US 
 FTI Consulting              Sage Strategic Marketing 
 Susan Stuart/Simon          Jennifer Guinan 
  Conway 
 Victoria Foster Mitchell    +1 610 410 8111 
 +44 (0) 20 7831 3113 
 

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon effective pathogen control including MRSA, e.Coli, and C. difficile. PuriCore is a leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. The Company's products are the de facto standard for food safety in leading US supermarket chains. PuriCore also offers a breakthrough wound therapy solution to treat chronic and acute wounds including diabetic ulcers and burns. PuriCore has operations in Malvern, Pennsylvania, US, and in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com, which does not form part of this announcement.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFIAVSISIIV

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024